Market
Overview:
Cardiac assist devices are medical devices
that have been specially designed for the patients suffering from
cardiomyopathy, myelopathy, congenital heart disease, or peripheral arterial
disease. These devices have been greatly useful in the treatment of patients
who are unable to pump blood efficiently throughout the body due to a cardiac
disorder or due to any other cardiac problem. Cardiac assist devices (CAD) are
blood pumps that support the circulatory functions of severely ill cardiac
patients. These pumps work along with the heart to improve the pumping
efficiency and maintain optimum blood flow throughout the body. These devices
are used to treat end-stage heart failure and are determined by the needs of
the individual.
Competitive
Landscape:
Major players operating in the global cardiacassist devices market are ABIOMED, Heart Ware International, Thoratec
Corporation, Teleflex Incorporated, Berlin Heart GmbH, MAQUET GmbH & Co.,
and SynCardia Systems, Inc., among others.
Key
Market Drivers:
High prevalence of cardiovascular diseases
(CVDs) around the world is expected to aid in the growth of the cardiac assist
devices market during the forecast period. For instance, as per the World
Health Organization (WHO), cardiovascular diseases (CVDs) are one of the
leading cause of death worldwide, taking an estimated 17.9 million lives each
year.
Moreover, increasing adoption of cardiac
assist devices in hospitals and homecare is expected to augment the growth of
the cardiac assist devices market. For instance, in June 2021, Abbott announced
the company has capacity and supply to effectively support the growing demand
for mechanical circulatory support (MCS) devices for the effective treatment of
advanced heart failure. Abbott is also supporting training and education
programs for physicians who will now be offering Abbott's HeartMate 3 heart
pumps to their patients.
Comments
Post a Comment